---
title: "Retro Green Revolution Ltd (519191) — Share Price, Financials & Analysis"
symbol: "519191"
company: "Retro Green Revolution Ltd"
canonical: "https://tapetide.com/stocks/519191"
isin: "INE601N01010"
nse_symbol: "RETROGREENREVOLUTIONLTD"
bse_code: "519191"
sector: "Consumer Goods"
industry: "Tea & Coffee"
market_cap_cr: 4.7
generated_at: "2026-09-13T19:15:54.002Z"
---

# Retro Green Revolution Ltd (519191)

Canonical page: https://tapetide.com/stocks/519191

## Company

- **NSE Symbol:** RETROGREENREVOLUTIONLTD
- **BSE Code:** 519191
- **ISIN:** INE601N01010
- **Sector:** Consumer Goods
- **Industry:** Tea & Coffee
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** retrogreenrevolution.com

## About

Incorporated in 1990, Retro Green Revolution Ltd is engaged in services industries and allied
activities.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:29.674989Z.

- **Market Cap:** ₹4.7 Cr
- **Classification:** Microcap
- **P/E (reported):** -62
- **EPS (TTM):** ₹-0.02
- **EPS (reported):** ₹0.52
- **Book Value:** ₹9.93
- **Price to Book:** 0.12
- **Dividend Yield:** 0%
- **ROE:** 0.11%
- **ROCE:** 0.14%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹1.39 Cr
- **Net Income:** ₹0.17 Cr
- **EBITDA:** ₹0.31 Cr
- **52-Week High:** ₹4.17
- **52-Week Low:** ₹0.95
- **RSI (14):** 44.51

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 66.51 | 9% |
| growth | 6.43 | 9% |
| momentum | 27.51 | 12% |
| ownership | 50 | 24% |
| quality | 43.81 | 22% |
| valuation | 47.09 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.12 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of 0.76% over last 3 years.
- Company has high debtors of 990 days.
- Working capital days have increased from 796 days to 1,513 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y |
| --- | --- | --- | --- |
| ebitda margin growth | 0% | 236.75% | -5.99% |
| net income growth | -0.1% | 70% | -66% |
| revenue growth | -100% | -48.52% | -11.42% |
| roce | 250% | -97.29% | -97.29% |
| roe | 200% | -97.96% | 2.75% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.7 | 0.7 | 0.61 | 0.12 | 0.08 | 0.07 | 0.04 |
| Expenses | 0.41 | 0.86 | 0.58 | 0.09 | 0.02 | 0.06 | 0.07 |
| Operating Profit | 0.29 | -0.16 | 0.03 | 0.03 | 0.06 | 0.01 | -0.03 |
| OPM % | 41.43 | -22.86 | 4.92 | 25 | 75 | 14.29 | -75 |
| Other Income | 0 | 0.04 | 0.05 | 0.02 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | 0.29 | -0.17 | 0.04 | 0.01 | 0.02 | -0.03 | -0.07 |
| Tax % | 0 | 11.76 | 25 | 100 | 50 | 0 | 0 |
| Net Profit | 0.29 | -0.18 | 0.03 | 0 | 0.02 | -0.02 | -0.06 |
| EPS in Rs | 0.08 | -0.05 | 0.01 | 0 | 0.01 | -0.01 | -0.02 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- |
| Sales | 2 | 2.16 | 1.39 | 0.31 |
| Expenses | 1.56 | 2.5 | 1.07 | 0.24 |
| Operating Profit | 0.44 | -0.34 | 0.32 | 0.07 |
| OPM % | 22 | -15.74 | 23.02 | 22.58 |
| Other Income | 0.03 | 0.51 | 0.02 | 0.02 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0.09 | 0.17 | 0.16 |
| Profit before tax | 0.47 | 0.08 | 0.17 | -0.07 |
| Tax % | 0 | 25 | 17.65 | — |
| Net Profit | 0.47 | 0.06 | 0.14 | -0.06 |
| EPS in Rs | 0.52 | 0.02 | 0.04 | -0.02 |
| Dividend Payout % | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Equity Capital | 9.04 | 38 | 38 |
| Reserves | -0.24 | 18 | -0.28 |
| Borrowings | 0.37 | 0.54 | 0.54 |
| Other Liabilities | 0.04 | 0.52 | 0.25 |
| Total Liabilities | 9.21 | 57.06 | 38.51 |
| Fixed Assets | 1.02 | 2 | 8.88 |
| CWIP | 0 | 0 | 0 |
| Investments | 5.37 | 46.37 | 21.03 |
| Other Assets | 2.82 | 8.69 | 8.6 |
| Total Assets | 9.21 | 57.06 | 38.51 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Cash from Operating Activity | 0.5 | 12.18 | -0.07 |
| Cash from Investing Activity | -0.48 | 0.01 | 0 |
| Cash from Financing Activity | 0.04 | -12.09 | 0 |
| Net Cash Flow | 0.05 | 0.1 | -0.07 |
| Free Cash Flow | 0.5 | 12.18 | -0.07 |
| CFO/OP | 5 | -3582 | -12 |

### Ratios

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Debtor Days | 93.08 | 687.75 | 989.96 |
| Inventory Days | — | — | 0 |
| Cash Conversion Cycle | 93.08 | 687.75 | 989.96 |
| Working Capital Days | 104.02 | 772.25 | 1512.52 |
| ROCE % | — | 0.24 | 0.36 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 92.89% | 92.7% | 93.19% | 92.2% | 91.66% | 30.51% | 30.64% | 39.59% | 50.15% | 49.77% | 51.04% | 51.13% |
| Others | 7.11% | 7.3% | 6.81% | 7.8% | 8.34% | 69.49% | 69.36% | 60.41% | 49.85% | 50.23% | 48.96% | 48.87% |
| No. of Shareholders | 7111 | 7131 | 7486 | 9799 | 11578 | 12414 | 12615 | 12777 | 13411 | 13686 | 13736 | 13911 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 7 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1.21 | Sell |
| EMA (10) | 1.21 | Sell |
| SMA (20) | 1.22 | Sell |
| EMA (20) | 1.24 | Sell |
| SMA (50) | 1.34 | Sell |
| EMA (50) | 1.32 | Sell |
| SMA (100) | 1.45 | Sell |
| EMA (100) | 1.43 | Sell |
| SMA (200) | 1.52 | Sell |
| EMA (200) | 1.94 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.71 | Neutral |
| MACD (12,26,9) | -0.04 | Buy |
| Stochastic (14,3,3) | 54.46 | Neutral |
| ADX (14) | 20.92 | Neutral |
| Williams %R (14) | -64.29 | Neutral |
| ATR (14) | 0.08 | High Volatility |
| ROC (12) | -0.83 | Sell |
| Stoch RSI (14) | 53.43 | Neutral |
| UO (7,14,28) | 49.01 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 31 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for Mar 31, 2026. | [Closure of Trading Window 31 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d4e90ca5-322c-471a-ac86-5b82fc5ccfbd.pdf) |
| 3 Mar - On March 03, 2026 Biocon acquired OCRPS worth Rs.1,15,34,42,850 and Rs.2,00,00,00,000 in two subsidiaries. | [Announcement under Regulation 30 (LODR)-Acquisition 3 Mar - On March 03, 2026 Biocon acquired OCRPS worth Rs.1,15,34,42,850 and Rs.2,00,00,00,000 in two subsidiaries.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d6982f9-73de-470a-badd-e0d451f6727a.pdf) |
| 3 Feb - Board meeting on Feb 11, 2026 to approve audited results for quarter and nine months ended Dec 31, 2025. | [Board Meeting Intimation for INTIMATION OF BOARD MEETING TO BE HELD ON 11/02/2026 TO DISCUSS QUARTERLY RESULT FOR DECEMBER, 2025 QUARTER. 3 Feb - Board meeting on Feb 11, 2026 to approve audited results for quarter and nine months ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8992fda2-7b57-428a-8bad-c1d3f69e3937.pdf) |
| 3 Apr - Retro Green Revolution signed non-binding MOU on 25 Mar 2026 to acquire up to 36%, potentially 100%, of Sevenglow Lights. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 3 Apr - Retro Green Revolution signed non-binding MOU on 25 Mar 2026 to acquire up to 36%, potentially 100%, of Sevenglow Lights.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0560530-4853-4674-b72b-6640c4e8c0b8.pdf) |
| 3 Apr - Retro Green Revolution signed MOU on 25 March 2026 to acquire up to 36% of Sevenglow Lights, potentially 100%. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 3 Apr - Retro Green Revolution signed MOU on 25 March 2026 to acquire up to 36% of Sevenglow Lights, potentially 100%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6e6e700-6354-4c1f-b22d-bf48dfb7e393.pdf) |
| 28 Apr - Company secretary Chaitali Upadhyaya resigned effective 30 March 2026. | [Intimation For Resignation Of Company Secretary 28 Apr - Company secretary Chaitali Upadhyaya resigned effective 30 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c201c774-9652-41e4-b73e-3d5712ecfd2c.pdf) |
| 28 Apr - Company secretary Chaitali Upadhyaya resigned effective 30 March 2026. | [Intimation For Resignation Of Company Secretary 28 Apr - Company secretary Chaitali Upadhyaya resigned effective 30 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c201c774-9652-41e4-b73e-3d5712ecfd2c.pdf) |
| 24 Feb - Biocon receives US FDA approval for Liraglutide (gSaxenda) 18mg/3mL prefilled pens, Feb 24, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Feb - Biocon receives US FDA approval for Liraglutide (gSaxenda) 18mg/3mL prefilled pens, Feb 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e844c347-ffbd-44e1-980a-c8b657efd8af.pdf) |
| 22 Jan - Board appointed three additional directors; Shweta Jain & Co auditor appointed wef 22-01-2026; office shifts wef 01-02-2026. | [Board Meeting Outcome for Outcome Of Board Meeting 22 Jan - Board appointed three additional directors; Shweta Jain & Co auditor appointed wef 22-01-2026; office shifts wef 01-02-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c47155cd-7575-4ccb-a9b4-f02af319bca6.pdf) |
| 2 Mar - Of Schedule of Meetings with Analyst(s)/Institutional Investor(s) | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2 Mar - Of Schedule of Meetings with Analyst(s)/Institutional Investor(s)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9fff2096-c565-4edf-83b0-1eef87a28082.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Board Meeting Outcome for Outcome Of Board Meeting Dated 7 September2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1c06c7d-e774-4d02-91fd-6d6af2fc5695.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bac4049-99cd-4921-b0da-7313eec455ff.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a05f5f0-ff8e-42e4-94f0-87ff63b0c0c6.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Unaudited Financial Result For The Quarter Ended 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72f039d1-f39e-4386-9599-08a3a3dbaba5.pdf) |
| 2026-07-23 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2abd21f-8faf-4c38-86f7-85ce864c7549.pdf) |
| 2026-07-14 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08d8cf89-6ae0-4eae-94a7-d55f2a3b60df.pdf) |
| 2026-06-30 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fd5c3ca-6bf5-4df7-b9a4-afb35ddf104f.pdf) |
| 2026-05-30 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2db9cfb0-0c49-46ab-8d10-c97a38a8a25f.pdf) |
| 2026-05-30 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3039dbd4-2fe0-4df0-b17d-7eab2f6121be.pdf) |
| 2026-05-19 | [Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65a92de7-7c99-409c-8f21-cfcbcb81ee41.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Results-Standalone And Consolidated Results For The Quarterly Ended 30June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a13f7c2c-5f3a-4866-8a84-3768deca15d5.pdf) |
| 2026-05-30 | [Financial Results For 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2acc8e9-62b9-4b56-a11c-11629dfa0689.pdf) |
| 2026-02-13 | [Quarterly Result For December 2025 Quarter](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=816a60ce-5ecb-42b2-8bf2-692061562737.pdf) |
| 2026-02-12 | [Outcome Of Unaudited Quarterly Result For December 2025 Quarter.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26adeedc-92d6-4963-9149-c695606d8fc5.pdf) |
| 2026-01-02 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb7a18d1-89e0-4247-b6a9-750fad42f4f8.pdf) |
| 2025-11-27 | [UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED 30.09.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27fb1e1e-2c8b-4620-ab19-e1755e303230.pdf) |
| 2025-08-18 | [Board Meeting Outcome for Delay In Outcome Of The Meeting Of The Board Of Directors Held On August 14 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=443d2ea2-4a5b-48de-a5f4-3e45fbccbf2e.pdf) |
| 2025-08-18 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2575e817-fd69-4037-9298-4315f7c95fab.pdf) |
| 2025-06-07 | [Audited Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b52549cf-ddf9-4fd6-bce7-d0487ca1f810.pdf) |
| 2025-03-10 | [Revised Unaudited Result For The Quarter Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=727bee48-fa12-457b-8e35-a0c5b7da72fe.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e02b47a5-f9d7-4e75-98d5-4b3d2df22c27.pdf) |
| Sep 2019 | [Concall - Sep 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7633f51-2d7b-4164-93e9-1096e0bd6940.pdf) |
| Sep 2019 | [Concall - Sep 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09eb87e9-8c5e-44a9-8798-646991afbec4.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/be7f9643-ee7d-4dd0-8053-f6ec4747fc19.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2a272c9-3495-4e33-81c5-a3d9ec77cfc2.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/baf1eafd-7d2f-4259-8adc-30d9296f9ca2.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f4a75b7-72bd-4888-8b47-2469eccba7a3.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1f49757-0537-431b-bb00-5c5cafaf9a69.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c31283ae-e622-476e-9ca6-776463e353ef.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9ffd54e-81f7-45b7-8f41-602f42d4eabf.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_BIOCON_2010_2011_15072011174501.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07f87bdb-8a15-4cb8-a50c-269e1955beff.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8dd107b8-bb03-47f4-8f6f-cbb37fcb6008.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9bcc7834-5992-4c19-b89e-b1e6899f450a.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ad9fa76-2716-4558-9923-4483b2048746.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8c17395-67a2-4bf5-a62b-9705ed2a2ec0.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2942d108-fa57-4eb7-b8c7-b26f718b63f3.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532523/73490532523.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/519191/77155519191.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532523/68687532523.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:15:54.002Z.